36.10
                                            Schlusskurs vom Vortag:
              $36.00
            Offen:
              $35.89
            24-Stunden-Volumen:
                411.91K
            Relative Volume:
              1.03
            Marktkapitalisierung:
                $1.14B
            Einnahmen:
              $566.77M
            Nettoeinkommen (Verlust:
              $48.16M
            KGV:
              30.34
            EPS:
                1.19
            Netto-Cashflow:
                $274.29M
            1W Leistung:
              +3.69%
            1M Leistung:
              +4.31%
            6M Leistung:
                +30.56%
            1J Leistung:
              +7.89%
            Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
                  
                      Collegium Pharmaceutical Inc
                    
                Sektor
                  Telefon
                  
                      781-713-3699
                    
                Adresse
                  
                      100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
                    
                Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                COLL
                            
                             
                        Collegium Pharmaceutical Inc 
                           | 
                    36.10 | 1.13B | 566.77M | 48.16M | 274.29M | 1.19 | 
| 
                         
                          
                                ZTS
                            
                             
                        Zoetis Inc 
                           | 
                    144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
| 
                         
                          
                                TAK
                            
                             
                        Takeda Pharmaceutical Co Adr 
                           | 
                    13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 | 
| 
                         
                          
                                HLN
                            
                             
                        Haleon Plc Adr 
                           | 
                    9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 | 
| 
                         
                          
                                TEVA
                            
                             
                        Teva Pharmaceutical Industries Ltd Adr 
                           | 
                    20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 | 
| 
                         
                          
                                UTHR
                            
                             
                        United Therapeutics Corp 
                           | 
                    438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 | 
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-01-10 | Hochstufung | Needham | Hold → Buy | 
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy | 
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy | 
| 2024-05-10 | Herabstufung | Needham | Buy → Hold | 
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral | 
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold | 
| 2023-08-25 | Bestätigt | Needham | Buy | 
| 2023-05-02 | Fortgesetzt | Jefferies | Buy | 
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight | 
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral | 
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy | 
| 2020-07-14 | Eingeleitet | BWS Financial | Sell | 
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral | 
| 2020-02-19 | Fortgesetzt | Jefferies | Buy | 
| 2019-10-30 | Bestätigt | Needham | Buy | 
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2019-04-12 | Fortgesetzt | Janney | Buy | 
| 2019-03-20 | Eingeleitet | SunTrust | Hold | 
| 2019-01-16 | Bestätigt | Needham | Buy | 
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy | 
| 2018-02-07 | Bestätigt | Needham | Buy | 
| 2017-12-05 | Bestätigt | Needham | Buy | 
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy | 
| 2017-05-11 | Bestätigt | Needham | Buy | 
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy | 
| 2015-06-01 | Eingeleitet | Jefferies | Buy | 
| 2015-06-01 | Eingeleitet | Needham | Buy | 
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight | 
                    Alle ansehen
                    
                  
                Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Will Collegium Pharmaceutical Inc. stock see PE expansion2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Will Collegium Pharmaceutical Inc. stock keep outperforming rivalsMarket Risk Report & Low Volatility Stock Recommendations - newser.com
Collegium Pharmaceutical Inc. stock outlook for YEARJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Is Collegium Pharmaceutical Inc. stock reversal real or fakeWeekly Gains Report & Consistent Profit Alerts - newser.com
How Collegium Pharmaceutical Inc. stock performs during Fed tightening cyclesQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Is Collegium Pharmaceutical Inc. stock a top pick in earnings season2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Can Collegium Pharmaceutical Inc. (354) stock hit consensus price targetsQuarterly Profit Report & Real-Time Stock Movement Alerts - newser.com
Will Collegium Pharmaceutical Inc. (354) stock profit from automation waveJuly 2025 Sentiment & Expert Verified Movement Alerts - newser.com
Is Collegium Pharmaceutical Inc. stock vulnerable to regulatory risksTrade Volume Report & Weekly Market Pulse Updates - newser.com
Why retail investors pile into Collegium Pharmaceutical Inc. stockEarnings Performance Report & Real-Time Stock Entry Alerts - newser.com
Will Collegium Pharmaceutical Inc. stock deliver better than expected guidanceEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Will Collegium Pharmaceutical Inc. stock gain from strong economyPortfolio Return Report & Low Risk High Reward Trade Ideas - newser.com
Can Collegium Pharmaceutical Inc. stock continue upward trendCEO Change & Free Community Consensus Stock Picks - newser.com
Collegium Pharmaceutical, Inc. (COLL) Stock forecasts - Yahoo! Finance UK
Collegium Pharmaceutical, Inc. (COLL) stock forecast and price target - Yahoo! Finance UK
Collegium Pharmaceutical, Inc. (COLL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo! Finance Canada
Collegium Pharmaceutical, Inc. (COLL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Real time breakdown of Collegium Pharmaceutical Inc. stock performanceSwing Trade & Safe Swing Trade Setups - newser.com
Measuring Collegium Pharmaceutical Inc.’s beta against major indicesPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Is Collegium Pharmaceutical Inc a good long term investmentInterest Rate Changes & The Future of Wealth Is Just a Click Away - earlytimes.in
Collegium Pharmaceutical Inc (COLL) Stock News & Articles - 24/7 Wall St.
Is Collegium Pharmaceutical Inc. stock recession proofMarket Growth Report & Community Consensus Stock Picks - newser.com
Emerald Mutual Fund Advisers Trust Trims Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Institutional scanner results for Collegium Pharmaceutical Inc.2025 Investor Takeaways & Real-Time Chart Breakout Alerts - newser.com
How interest rate cuts could boost Collegium Pharmaceutical Inc. stockQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Is Collegium Pharmaceutical Inc. (354) stock inflation resilientEarnings Growth Report & Community Verified Swing Trade Signals - newser.com
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):